insights_auto
Nega EDIT tushdi 9,91%?
Batafsil oʻrganishchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,96 US$
arrow_downward
-9,91%(-0,22) 1K
16-noy, 13:06:54 (GMT-5) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoEDIT tikeri uchun statistika yaratilmoqda...
Ochish
2,10 US$
Yuqori
2,12 US$
Past
1,95 US$
Bozor kapitali
301,73 mln
Oʻrtacha hajm
2,44 mln
Hajmi
1,04 mln
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,62 US$
Beta
2,09
Muomaladagi aksiyalar
154,34 mln
Xodimlar soni
87
Ochish
2,10 US$
Yuqori
2,12 US$
Past
1,95 US$
Bozor kapitali
301,73 mln
Oʻrtacha hajm
2,44 mln
Hajmi
1,04 mln
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,62 US$
Beta
2,09
Muomaladagi aksiyalar
154,34 mln
Xodimlar soni
87
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
ChartMill
·
32 daqiqa oldin
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
marketscreener.com
·
38 daqiqa oldin
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
Stocktwits
·
38 daqiqa oldin
Morgan Stanley’s Mike Wilson Is Bullish On S&P 500 With A 15% Upside View For 2027
Traders Union
·
2 soat oldin
Peter Tuchman: S&P 500 loses over $800 billion in market cap
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc haqida
CEO-
Xodimlar soni87
Asos solingannoy 2013
Bosh ofislar-
SektorHealth Care
Soha-
Veb-sayteditasmedicine.com